Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center.

Michele SpinicciIacopo VellereLucia GrazianiMarta TilliBeatrice BorchiJessica MencariniIrene CampolmiLeonardo GoriLaura RaseroFrancesco FattirolliIacopo OlivottoFederico LavoriniNiccolò Marchionni Lorenzo ZammarchiAlessandro Bartoloninull null

Published in: Open forum infectious diseases (2021)

We evaluated 100 postacute coronavirus disease 2019 (COVID-19) patients a median (interquartile range) of 60 (48-67) days after discharge from the Careggi University Hospital, Italy. Eighty-four (84%) had at least 1 persistent symptom, irrespective of COVID-19 severity. A considerable number of hospital readmissions (10%) and/or infectious diseases (14%) during the postdischarge period were reported.

Keyphrases

coronavirus disease
infectious diseases
sars cov
tertiary care
respiratory syndrome coronavirus
healthcare
adverse drug